{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:09:44Z","timestamp":1771981784868,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jogoh.2026.103108","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:03:17Z","timestamp":1767686597000},"page":"103108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the role of secondary surgery and PARP inhibition in platinum-sensitive ovarian cancer relapse"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2374-7030","authenticated-orcid":false,"given":"Stefano","family":"Fucina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00f2","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Del Fabro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Martella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Baldassarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Giudici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Canzonieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Ditto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2026.103108_bib0001","article-title":"Global incidence of ovarian cancer according to histologic subtype: a population-based cancer registry study","volume":"10","author":"Wang","year":"2024","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.jogoh.2026.103108_bib0002","article-title":"The role of secondary surgery in recurrent ovarian cancer","author":"Lorusso","year":"2012","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.jogoh.2026.103108_bib0003","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2026.103108_bib0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/ijgc-2022-004149","article-title":"Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directions","volume":"33","author":"Caruso","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogoh.2026.103108_bib0005","doi-asserted-by":"crossref","DOI":"10.21037\/gpm-2020-13","article-title":"Surgery for recurrent ovarian cancer: expert point of view","volume":"4","author":"Sch\u00fctz","year":"2021","journal-title":"Gynecol Pelvic Med"},{"key":"10.1016\/j.jogoh.2026.103108_bib0006","doi-asserted-by":"crossref","unstructured":"Du Bois, Andreas, et al. \"Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III\/ENGOT ov20.\" (2017).","DOI":"10.1200\/JCO.2017.35.15_suppl.5501"},{"key":"10.1016\/j.jogoh.2026.103108_bib0007","doi-asserted-by":"crossref","unstructured":"Zang, Rongyu, et al. \"A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1\/SGOG-OV2.\" (2020).","DOI":"10.1200\/JCO.2020.38.15_suppl.6001"},{"key":"10.1016\/j.jogoh.2026.103108_bib0008","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1902626","article-title":"Secondary surgical cytoreduction for recurrent ovarian cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2026.103108_bib0009","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0b013e31820aaafd","article-title":"Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the multicenter intergroup study DESKTOP II","volume":"21","author":"Harter","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogoh.2026.103108_bib0010","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-011-1873-2","article-title":"A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection","volume":"19","author":"Tian","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jogoh.2026.103108_bib0011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO\u2013ESMO\u2013ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease\u2606","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jogoh.2026.103108_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2024.03.006","article-title":"Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer","volume":"186","author":"Ehmann","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogoh.2026.103108_bib0013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejso.2024.108383","article-title":"Outcomes of secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer progressed after prior PARPi: a retrospective cohort study","volume":"50","author":"Zhao","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jogoh.2026.103108_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-023-03230-3","article-title":"Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer","volume":"21","author":"Zou","year":"2023","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.jogoh.2026.103108_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-021-00842-9","article-title":"The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis","volume":"14","author":"Ding","year":"2021","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.jogoh.2026.103108_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejogrb.2025.01.025","article-title":"Secondary cytoreductive surgery for ovarian cancer recurrence and first-line maintenance therapy: a multicenter retrospective study","volume":"306","author":"Uccella","year":"2025","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2026.103108_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3802\/jgo.2020.31.e61","article-title":"A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study","volume":"31","author":"Shi","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.jogoh.2026.103108_bib0018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/ijgc-2024-005838","article-title":"A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study. S.l","volume":"34","author":"Cho","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogoh.2026.103108_bib0019","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ijgc-2023-004978","article-title":"Secondary cytoreduction surgery for recurrent epithelial ovarian cancer patients after PARPi maintenance: a multicenter, randomized, controlled clinical trial","volume":"34","author":"Chen","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogoh.2026.103108_bib0020","first-page":"1","article-title":"Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study","volume":"35","author":"Chen","year":"2023","journal-title":"J Gynecol Oncol"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878472600005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878472600005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:43:14Z","timestamp":1771980194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246878472600005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S246878472600005X"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2026.103108","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the role of secondary surgery and PARP inhibition in platinum-sensitive ovarian cancer relapse","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2026.103108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103108"}}